These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25702318)

  • 1. The effect of infliximab on depressive symptoms in patients with ankylosing spondylitis.
    Ersözlü-Bozkırlı ED; Keşkek SO; Bozkırlı E; Yücel AE
    Acta Reumatol Port; 2015; 40(3):262-7. PubMed ID: 25702318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis.
    Rahman P; Choquette D; Bensen WG; Khraishi M; Chow A; Zummer M; Shaikh S; Sheriff M; Dixit S; Sholter D; Psaradellis E; Sampalis JS; Letourneau V; Lehman AJ; Nantel F; Rampakakis E; Otawa S; Shawi M
    BMJ Open; 2016 Apr; 6(4):e009661. PubMed ID: 27048632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade.
    Syngle A; Vohra K; Sharma A; Kaur L
    Clin Rheumatol; 2010 Jul; 29(7):763-70. PubMed ID: 20204669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab, a TNF-α antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level.
    Ertenli I; Ozer S; Kiraz S; Apras SB; Akdogan A; Karadag O; Calguneri M; Kalyoncu U
    Rheumatol Int; 2012 Feb; 32(2):323-30. PubMed ID: 21079965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies.
    Cardiel MH; Londoño JD; Gutiérrez E; Pacheco-Tena C; Vázquez-Mellado J; Burgos-Vargas R
    Clin Exp Rheumatol; 2003; 21(4):451-8. PubMed ID: 12942696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs.
    Perrotta FM; Addimanda O; Ramonda R; D'Angelo S; Lubrano E; Marchesoni A; Olivieri I; Punzi L; Salvarani C; Spadaro A
    Reumatismo; 2014 Nov; 66(3):208-14. PubMed ID: 25376955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement.
    Rejón E; Giménez MD; Mayordomo L; Rodríguez S; González MP; Marenco JL
    Scand J Rheumatol; 2004; 33(5):323-6. PubMed ID: 15513681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of the Thai version of bath ankylosing spondylitis indices.
    Kittiyanpanya C; Chaiamnuay S; Asavatanabodee P; Narongroeknawin P
    J Med Assoc Thai; 2014 Apr; 97(4):381-5. PubMed ID: 24964679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT).
    Webers C; Stolwijk C; Schiepers O; Schoonbrood T; van Tubergen A; Landewé R; van der Heijde D; Boonen A
    Arthritis Res Ther; 2020 Sep; 22(1):225. PubMed ID: 32993799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study.
    Capkin E; Karkucak M; Cosar AM; Ak E; Karaca A; Gokmen F; Budak BS; Tosun M
    Int J Rheum Dis; 2015 Jun; 18(5):548-52. PubMed ID: 24612551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerobic capacity and its correlates in patients with ankylosing spondylitis.
    Hsieh LF; Wei JC; Lee HY; Chuang CC; Jiang JS; Chang KC
    Int J Rheum Dis; 2016 May; 19(5):490-9. PubMed ID: 24754841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.
    Braun J; Baraliakos X; Brandt J; Listing J; Zink A; Alten R; Burmester G; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Sieper J
    Rheumatology (Oxford); 2005 May; 44(5):670-6. PubMed ID: 15757965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety.
    Maksymowych WP; Jhangri GS; Lambert RG; Mallon C; Buenviaje H; Pedrycz E; Luongo R; Russell AS
    J Rheumatol; 2002 May; 29(5):959-65. PubMed ID: 12022358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab in severe active ankylosing spondylitis with spinal ankylosis.
    Cheung PP; Tymms KE; Wilson BJ; Shadbolt B; Brook AS; Dorai Raj AK; Khoo KB
    Intern Med J; 2008 Jun; 38(6):396-401. PubMed ID: 18336538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
    Elkayam O; Bashkin A; Mandelboim M; Litinsky I; Comaheshter D; Levartovsky D; Mendelson E; Wigler I; Caspi D; Paran D
    Semin Arthritis Rheum; 2010 Jun; 39(6):442-7. PubMed ID: 19246078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life and Clinical Response to On-Demand Maintenance Doses of Infliximab in Patients With Ankylosing Spondylitis.
    Sengupta S; Ray J; Ghosh B
    J Clin Rheumatol; 2015 Oct; 21(7):355-8. PubMed ID: 26398462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
    van der Heijde D; Landewé R; Baraliakos X; Houben H; van Tubergen A; Williamson P; Xu W; Baker D; Goldstein N; Braun J;
    Arthritis Rheum; 2008 Oct; 58(10):3063-70. PubMed ID: 18821688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study.
    Park W; Yoo DH; Jaworski J; Brzezicki J; Gnylorybov A; Kadinov V; Sariego IG; Abud-Mendoza C; Escalante WJ; Kang SW; Andersone D; Blanco F; Hong SS; Lee SH; Braun J
    Arthritis Res Ther; 2016 Jan; 18():25. PubMed ID: 26795209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis.
    Stone M; Salonen D; Lax M; Payne U; Lapp V; Inman R
    J Rheumatol; 2001 Jul; 28(7):1605-14. PubMed ID: 11469469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.